Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHROMOSOME 9P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ogata, T; Muroya, K; Ohashi, H; Mochizuki, H; Hasegawa, T; Kaji, M
      Female gonadal development in XX patients with distal 9p monosomy

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    2. Miracca, EC; Yamamoto, L; Contado, D; Takimoto, MDS; Kowalski, LP; Nagai, MA
      Distinct chromosomal deleted regions defining different subsets of head and neck tumors

      DIAGNOSTIC MOLECULAR PATHOLOGY
    3. Puig, S; Castro, J; Ventura, PJ; Ruiz, A; Ascaso, C; Melvehy, J; Estivill, X; Mascaro, JM; Lecha, M; Castel, T
      Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases

      MELANOMA RESEARCH
    4. Calvari, V; Bertini, V; De Grandi, A; Peverali, G; Zuffardi, O; Ferguson-Smith, M; Knudtzon, J; Camerino, G; Borsani, G; Guioli, S
      A new submicroscopic deletion that refines the 9p region for sex reversal

      GENOMICS
    5. M'soka, TJ; Nishioka, J; Taga, A; Kato, K; Kawasaki, H; Yamada, Y; Yu, A; Komada, Y; Nobori, T
      Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay

      LEUKEMIA
    6. Chen, TC; Hsieh, LL; Kuo, TT; Ng, KF; Chou, YHW; Jeng, LB; Chen, MF
      p16(INK4) gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma

      ANTICANCER RESEARCH
    7. Franchi, PG; Calabrese, G; Morizio, E; Modestini, E; Stuppia, L; Mingarelli, R; Palka, G
      FISH analysis in detecting 9p duplication (p22p24)

      AMERICAN JOURNAL OF MEDICAL GENETICS
    8. Schraml, P; Muller, D; Bednar, R; Gasser, T; Sauter, G; Mihatsch, MJ; Moch, H
      Allelic loss at the D9S171 focus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma

      JOURNAL OF PATHOLOGY
    9. Baurain, JF; Colau, D; van Baren, N; Landry, C; Martelange, V; Vikkula, M; Boon, T; Coulie, PG
      High frequency of autologous anti-melanoma CTL directed against an antigengenerated by a point mutation in a new helicase gene

      JOURNAL OF IMMUNOLOGY
    10. Muroya, K; Okuyama, T; Goishi, K; Ogiso, Y; Fukuda, S; Kameyama, J; Sato, H; Suzuki, Y; Terasaki, H; Gomyo, H; Wakui, K; Fukushima, Y; Ogata, T
      Sex-determining gene(s) on distal 9p: Clinical and molecular studies in six cases

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    11. van der Velden, PA; Sandkuijl, LA; Bergman, W; Hille, ETM; Frants, RR; Gruis, NA
      A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families

      GENOME RESEARCH
    12. Watson, JEV; Gabra, H; Taylor, KJ; Rabiasz, GJ; Morrison, H; Perry, P; Smyth, JF; Porteous, DJ
      Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis

      GENOME RESEARCH
    13. Holland, EA; Schmid, H; Kefford, RF; Mann, GJ
      CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas

      GENES CHROMOSOMES & CANCER
    14. Wu, CL; Roz, L; McKown, S; Sloan, P; Read, AP; Holland, S; Porter, S; Scully, C; Paterson, L; Tavassoli, M; Thakker, N
      DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas

      GENES CHROMOSOMES & CANCER
    15. Wistuba, II; Behrens, C; Milchgrub, S; Bryant, D; Hung, J; Minna, JD; Gazdar, AF
      Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

      ONCOGENE
    16. Fujimoto, A; Morita, R; Hatta, N; Takehara, K; Takata, M
      p16(INK4a) inactivation is not frequent in uncultured sporadic primary cutaneous melanoma

      ONCOGENE
    17. Takeshita, H; Sato, M; Shiwaku, HO; Semba, S; Sakurada, A; Hoshi, M; Hayashi, Y; Tagawa, Y; Ayabe, H; Horii, A
      Expression of the DMBT1 gene is frequently suppressed in human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    18. Rao, UNM; Bakker, A; Swalsky, PA; Finkelstein, SD
      Max interacting protein 1: Loss of heterozygosity is frequent in desmoplastic melanoma

      MODERN PATHOLOGY
    19. Shaw, ME; Elder, PA; Abbas, A; Knowles, MA
      Partial allelotype of schistosomiasis-associated bladder cancer

      INTERNATIONAL JOURNAL OF CANCER
    20. An, HX; Claas, A; Savelyeva, L; Seitz, S; Schlag, P; Scherneck, S; Schwab, M
      Two regions of deletion in 9p23-24 in sporadic breast cancer

      CANCER RESEARCH
    21. Miracca, EC; Kowalski, LP; Nagai, MA
      High prevalence of p16 genetic alterations in head and neck tumours

      BRITISH JOURNAL OF CANCER
    22. Bishop, JAN; Harland, M; Bennett, DC; Bataille, V; Goldstein, AM; Tucker, MA; Ponder, BAJ; Cuzick, J; Selby, P; Bishop, DT
      Mutation testing in melanoma families: INK4A, CDK4 and INK4D

      BRITISH JOURNAL OF CANCER
    23. SAAR K; SCHINDLER D; WEGNER RD; REIS A; WIENKER TF; HOEHN H; JOENJE H; SPERLING K; DIGWEED M
      LOCALIZATION OF A FANCONI-ANEMIA GENE TO CHROMOSOME 9P

      European journal of human genetics
    24. SOUFIR N; AVRIL MF; CHOMPRET A; DEMENAIS F; BOMBLED J; SPATZ A; STOPPALYONNET D; BENARD J; BRESSACDEPAILLERETS B
      PREVALENCE OF P16 AND CDK4 GERMLINE MUTATIONS IN 48 MELANOMA-PRONE FAMILIES IN FRANCE

      Human molecular genetics
    25. SCHMID M; MALICKI D; NOBORI T; ROSENBACH MD; CAMPBELL K; CARSON DA; CARRERA CJ
      HOMOZYGOUS DELETIONS OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) ARE MORE FREQUENT THAN P16(INK4A) (CDKN2) HOMOZYGOUS DELETIONS IN PRIMARY NONSMALL CELL LUNG CANCERS (NSCLC)

      Oncogene
    26. QUEZADO MM; ABATI AD; ALBUQUERQUE AV; WILSON J; MERINO MJ; FILIE AC
      MORPHOLOGIC DIVERSITY IN MALIGNANT-MELANOMA - THE POTENTIAL USE OF MICRODISSECTION AND THE POLYMERASE-CHAIN-REACTION FOR DIAGNOSIS

      Modern pathology
    27. AITKEN JF; BAILEYWILSON J; GREEN AC; MACLENNAN R; MARTIN NG
      SEGREGATION ANALYSIS OF CUTANEOUS MELANOMA IN QUEENSLAND

      Genetic epidemiology
    28. RYAN A; ALJEHANI RM; MULLIGAN KT; JACOBS IJ
      NO EVIDENCE EXISTS FOR METHYLATION INACTIVATION OF THE P16 TUMOR-SUPPRESSOR GENE IN OVARIAN CARCINOGENESIS

      Gynecologic oncology
    29. DAVIES AF; IMAIZUMI K; MIRZA G; STEPHENS RS; KUROKI Y; MATSUNO M; RAGOUSSIS J
      FURTHER EVIDENCE FOR THE INVOLVEMENT OF HUMAN-CHROMOSOME 6P24 IN THE ETIOLOGY OF OROFACIAL CLEFTING

      Journal of Medical Genetics
    30. Fargnoli, MC; Chimenti, S; Keller, G; Soyer, HP; Dal Pozzo, V; Hofler, H; Peris, K
      CDKN2a/p16(INK4a) mutations and lack of 0p19(ARF) involvement in familial melanoma kindreds

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    31. RUIZ A; PUIG S; LYNCH M; CASTEL T; ESTIVILL X
      RETENTION OF THE CDKN2A LOCUS AND LOW-FREQUENCY OF POINT MUTATIONS INPRIMARY AND METASTATIC CUTANEOUS MALIGNANT-MELANOMA

      International journal of cancer
    32. FOULKES WD; FLANDERS TY; POLLOCK PM; HAYWARD NK
      THE CDKN2A (P16) GENE AND HUMAN CANCER

      Molecular medicine
    33. HASTHORPE S; HOLLAND KA; NINK V; LAWLER CB; HERTZOG PJ
      MECHANISMS OF RESISTANCE OFF NSCLC TO INTERFERONS - CORRELATION WITH RECEPTOR REGULATION AND TYPE-I IFN GENE DELETION

      International journal of oncology
    34. BOUZYK M; BRYANT SP; EVANS C; GUIOLI S; FORD S; SCHMIDT K; GOODFELLOW PN; POVEY S; REBELLO M; ROUSSEAUX S; SPURR NK
      INTEGRATED RADIATION HYBRID AND YEAST ARTIFICIAL CHROMOSOME MAP OF CHROMOSOME 9P

      European journal of human genetics
    35. HARLAND M; MELONI R; GRUIS N; PINNEY E; BROOKES S; SPURR NK; FRISCHAUF AM; BATAILLE V; PETERS G; CUZICK J; SELBY P; BISHOP DT; BISHOP JN
      GERMLINE MUTATIONS OF THE CDKN2 GENE IN UK MELANOMA FAMILIES

      Human molecular genetics
    36. FLORES JF; POLLOCK PM; WALKER GJ; GLENDENING JM; LIN AHT; PALMER JM; WALTERS MK; HAYWARD NK; FOUNTAIN JW
      ANALYSIS OF THE CDKN2A, CDKN2B AND CDK4 GENES IN 48 AUSTRALIAN MELANOMA KINDREDS

      Oncogene
    37. CASTRESANA JS; GOMEZ L; GARCIAMIGUEL P; QUEIZAN A; PESTANA A
      MUTATIONAL ANALYSIS OF THE P16 GENE IN HUMAN NEUROBLASTOMAS

      Molecular carcinogenesis
    38. AGUIAR RCT; SILL H; GOLDMAN JM; CROSS NCP
      THE COMMONLY DELETED REGION AT 9P21-22 IN LYMPHOBLASTIC LEUKEMIAS SPANS AT LEAST 400 KB AND INCLUDES P16 BUT NOT P15 OR THE IFN GENE-CLUSTER

      Leukemia
    39. WIEST JS; FRANKLIN WA; DRABKIN H; GEMMILL R; SIDRANSKY D; ANDERSON MW
      GENETIC-MARKERS FOR EARLY DETECTION OF LUNG-CANCER AND OUTCOME MEASURES FOR RESPONSE TO CHEMOPREVENTION

      Journal of cellular biochemistry
    40. PUIG S; RUIZ A; CASTEL T; VOLPINI V; MALVEHY J; CARDELLACH F; LYNCH M; MASCARO JM; ESTIVILL X
      INHERITED SUSCEPTIBILITY TO SEVERAL CANCERS BUT ABSENCE OF LINKAGE BETWEEN DYSPLASTIC NEVUS SYNDROME AND CDKN2A IN A MELANOMA FAMILY WITH AMUTATION IN THE CDKN2A (P16INK4A) GENE

      Human genetics
    41. OGATA T; MUROYA I; MATSUO N; HATA J; FUKUSHIMA Y; SUZUKI Y
      IMPAIRED MALE SEX DEVELOPMENT IN AN INFANT WITH MOLECULARLY DEFINED PARTIAL 9P MONOSOMY - IMPLICATION FOR A TESTIS FORMING GENE(S) ON 9P

      Journal of Medical Genetics
    42. SHIH YC; KERR J; LIU J; HURST T; KHOO SK; WARD B; WAINWRIGHT B; CHENEVIXTRENCH G
      RARE MUTATIONS AND NO HYPERMETHYLATION AT THE CDKN2A LOCUS IN EPITHELIAL OVARIAN-TUMORS

      International journal of cancer
    43. BACK E; JUNG C; ZEITLER S; SCHEMPP W
      DE-NOVO DUPLICATION OF 7PTER-]P21.2 AND DELETION OF 9PTER-]P23.5 - CLINICAL AND CYTOGENETIC DIAGNOSIS

      Clinical genetics
    44. GONZALGO ML; BENDER CM; YOU EH; GLENDENING JM; FLORES JF; WALKER GJ; HAYWARD NK; JONES PA; FOUNTAIN JW
      LOW-FREQUENCY OF P16 CDKN2A METHYLATION IN SPORADIC MELANOMA - COMPARATIVE APPROACHES FOR METHYLATION ANALYSIS OF PRIMARY TUMORS/

      Cancer research
    45. CASTELLANO M; POLLOCK PM; WALTERS MK; SPARROW LE; DOWN LM; GABRIELLI BG; PARSONS PG; HAYWARD NK
      CDKN2A P16 IS INACTIVATED IN MOST MELANOMA CELL-LINES/

      Cancer research
    46. SCHMIDT EE; ICHIMURA K; MESSERLE KR; GOIKE HM; COLLINS VP
      INFREQUENT METHYLATION OF CDKN2A(MTS1 P16) AND RARE MUTATION OF BOTH CDKN2A AND CDKN2B(MTS2/P15) IN PRIMARY ASTROCYTIC TUMORS/

      British Journal of Cancer
    47. GOLDSTEIN AM; TUCKER MA
      SCREENING FOR CDKN2A MUTATIONS IN HEREDITARY MELANOMA

      Journal of the National Cancer Institute
    48. GOLDSTEIN AM; CLARK WH; FRASER MC; TUCKER MA
      APPARENT ANTICIPATION IN FAMILIAL MELANOMA

      Melanoma research
    49. BRIOLLAIS L; CHOMPRET A; GUILLOUDBATAILLE M; FEINGOLD N; AVRIL MF; DEMENAIS F
      GENETIC AND EPIDEMIOLOGIC RISK-FACTORS FOR A MALIGNANT MELANOMA-PREDISPOSING PHENOTYPE - THE GREAT NUMBER OF NEVI

      Genetic epidemiology
    50. HORWITZ M; SABATH DE; SMITHSON WA; RADICH J
      A FAMILY INHERITING DIFFERENT SUBTYPES OF ACUTE MYELOGENOUS LEUKEMIA

      American journal of hematology
    51. HUI AM; SAKAMOTO M; KANAI Y; INO Y; GOTOH M; YOKOTA J; HIROHASHI S
      INACTIVATION OF P16(INK4) IN HEPATOCELLULAR-CARCINOMA

      Hepatology
    52. DRACOPOLI NC; FOUNTAIN JW
      CDKN2 MUTATIONS IN MELANOMA

      Cancer surveys
    53. EASTON D
      THE ROLE OF ATYPICAL MOLE SYNDROME AND CUTANEOUS NEVI IN THE DEVELOPMENT OF MELANOMA

      Cancer surveys
    54. MARUNO M; YOSHIMINE T; MUHAMMAD AKMG; TOKIYOSHI K; HAYAKAWA T
      LOSS OF HETEROZYGOSITY OF MICROSATELLITE LOCI ON CHROMOSOME 9P IN ASTROCYTIC TUMORS AND ITS PROGNOSTIC IMPLICATIONS

      Journal of neuro-oncology
    55. CANNONALBRIGHT LA; KAMB A; SKOLNICK M
      A REVIEW OF INHERITED PREDISPOSITION TO MELANOMA

      Seminars in oncology
    56. PETRONIO J; HE J; FULTS D; PEDONE C; JAMES CD; ALLEN JR
      COMMON ALTERNATIVE GENE ALTERATIONS IN ADULT MALIGNANT ASTROCYTOMAS, BUT NOT IN CHILDHOOD PRIMITIVE NEUROECTODERMAL TUMORS - P16INK4 HOMOZYGOUS DELETIONS AND CDK4 GENE AMPLIFICATIONS

      Journal of neurosurgery
    57. HEALY E; SIKKINK S; REES JL
      INFREQUENT MUTATION OF P16(INK4) IN SPORADIC MELANOMA

      Journal of investigative dermatology
    58. FLORES JF; WALKER GJ; GLENDENING JM; HALUSKA FG; CASTRESANA JS; RUBIO MP; PASTORFIDE GC; BOYER LA; KAO WH; BULYK ML; BARNHILL RL; HAYWARD NK; HOUSMAN DE; FOUNTAIN JW
      LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA

      Cancer research
    59. PLATZ A; SEVIGNY P; NORBERG T; RING P; LAGERLOF B; RINGBORG U
      GENES INVOLVED IN CELL-CYCLE G(1) CHECKPOINT CONTROL ARE FREQUENTLY MUTATED IN HUMAN-MELANOMA METASTASES

      British Journal of Cancer
    60. GENG YP; YU DH; BLATT LM; TAYLOR MW
      TUMOR-SUPPRESSOR ACTIVITY OF THE HUMAN CONSENSUS TYPE-I INTERFERON GENE

      Cytokines and molecular therapy
    61. NORMAN MG; HARRISON KJ; POSKITT KJ; KALOUSEK DK
      DUPLICATION OF 9P AND HYPERPLASIA OF THE CHOROID-PLEXUS - A PATHOLOGICAL, RADIOLOGIC, AND MOLECULAR CYTOGENETICS STUDY

      PEDIATRIC PATHOLOGY & LABORATORY MEDICINE
    62. RODABAUGH KJ; BIGGS RB; QURESHI JA; BARRETT AJ; WELCH WR; BELL DA; BERKOWITZ RS; MOK SC
      DETAILED DELETION MAPPING OF CHROMOSOME 9P AND P16 GENE ALTERATIONS IN HUMAN BORDERLINE AND INVASIVE EPITHELIAL OVARIAN-TUMORS

      Oncogene
    63. NEVILLE EM; STEWART M; MYSKOW M; DONNELLY RJ; FIELD JK
      LOSS OF HETEROZYGOSITY AT 9P23 DEFINES A NOVEL LOCUS IN NONSMALL CELLLUNG-CANCER

      Oncogene
    64. SAKATA K; TAMURA G; MAESAWA C; SUZUKI Y; TERASHIMA M; SATOH K; EDA Y; SUZUKI A; SEKIYAMA S; SATODATE R
      LOSS OF HETEROZYGOSITY ON THE SHORT ARM OF CHROMOSOME-9 WITHOUT P16 GENE MUTATION IN GASTRIC CARCINOMAS

      Japanese journal of cancer research
    65. GRUIS NA; SANDKUIJL LA; WEBER JL; VANDERZEE A; BORGSTEIN AM; BERGMAN W; FRANTS RR
      LINKAGE ANALYSIS IN DUTCH FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA (FAMMM) SYNDROME FAMILIES - EFFECT OF NEVUS COUNT

      Melanoma research
    66. TEEBI AS; GIBSON L; MCGRATH J; MEYN MS; BREG WR; YANGFENG TL
      MOLECULAR AND CYTOGENETIC CHARACTERIZATION OF 9P-ABNORMALITIES

      American journal of medical genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:18:29